Abstract
Crystal structures of small molecules (i.e. isolated ligands) are a source of valuable structural information helpful in the process of drug design (pharmacophore model elaborations, 3D QSAR, docking, and de novo design). Indeed, structural data obtained from small molecules crystallography can approach ligand-receptor binding by providing unique structural features both about the conformation (internal geometry) of the ligand (s) and about the intermolecular interaction potentially occurring within the active site of a target (enzyme receptor). Small molecule crystal structure databases can also be used in three dimensional search to identify new drug candidates. Future development in small molecule crystallography (e.g. powder diffraction) should also provide original solutions to complex problems related to polymorphism.
Keywords: Small Molecule Crystallography, 3D QSAR, protein coupled, structure based drug design, Non Polar Molecules, Retinoic acid crystallizes, neuraminidase, Fab fragment, free energy solution, MIMUMBA program, protein ligand docking
Current Pharmaceutical Design
Title: Small Molecule Crystallography in Drug Design
Volume: 7 Issue: 7
Author(s): Johan Wouters and Frederic Ooms
Affiliation:
Keywords: Small Molecule Crystallography, 3D QSAR, protein coupled, structure based drug design, Non Polar Molecules, Retinoic acid crystallizes, neuraminidase, Fab fragment, free energy solution, MIMUMBA program, protein ligand docking
Abstract: Crystal structures of small molecules (i.e. isolated ligands) are a source of valuable structural information helpful in the process of drug design (pharmacophore model elaborations, 3D QSAR, docking, and de novo design). Indeed, structural data obtained from small molecules crystallography can approach ligand-receptor binding by providing unique structural features both about the conformation (internal geometry) of the ligand (s) and about the intermolecular interaction potentially occurring within the active site of a target (enzyme receptor). Small molecule crystal structure databases can also be used in three dimensional search to identify new drug candidates. Future development in small molecule crystallography (e.g. powder diffraction) should also provide original solutions to complex problems related to polymorphism.
Export Options
About this article
Cite this article as:
Wouters Johan and Ooms Frederic, Small Molecule Crystallography in Drug Design, Current Pharmaceutical Design 2001; 7 (7) . https://dx.doi.org/10.2174/1381612013397889
DOI https://dx.doi.org/10.2174/1381612013397889 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements